Kyongbo Pharmaceutical Co Ltd banner

Kyongbo Pharmaceutical Co Ltd
KRX:214390

Watchlist Manager
Kyongbo Pharmaceutical Co Ltd Logo
Kyongbo Pharmaceutical Co Ltd
KRX:214390
Watchlist
Price: 7 150 KRW -9.95% Market Closed
Market Cap: ₩171B

Income Statement

Earnings Waterfall
Kyongbo Pharmaceutical Co Ltd

Income Statement
Kyongbo Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: KRW
Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025 Dec-2025
Revenue
Interest Expense
1 085
841
875
727
878
796
746
868
960
1 001
1 014
1 031
1 005
892
820
834
889
1 031
1 168
1 199
1 298
0
0
0
1 307
0
0
0
1 176
0
0
0
1 671
0
0
0
3 401
0
0
0
4 290
0
0
0
0
Revenue
169 781
N/A
171 582
+1%
173 668
+1%
177 835
+2%
178 033
+0%
179 561
+1%
187 025
+4%
188 604
+1%
186 726
-1%
187 216
+0%
187 223
+0%
186 980
0%
191 661
+3%
193 555
+1%
193 147
0%
196 804
+2%
201 344
+2%
198 997
-1%
201 164
+1%
196 170
-2%
191 706
-2%
198 597
+4%
205 907
+4%
215 348
+5%
215 285
0%
207 172
-4%
193 037
-7%
177 260
-8%
170 660
-4%
169 982
0%
170 024
+0%
180 396
+6%
196 265
+9%
201 204
+3%
207 651
+3%
212 902
+3%
216 357
+2%
231 004
+7%
236 861
+3%
240 510
+2%
238 556
-1%
236 544
-1%
243 445
+3%
252 201
+4%
264 104
+5%
Gross Profit
Cost of Revenue
(119 976)
(124 254)
(126 470)
(130 651)
(129 475)
(130 974)
(139 287)
(143 666)
(142 623)
(141 825)
(139 725)
(133 443)
(137 039)
(139 601)
(140 267)
(147 556)
(152 082)
(152 466)
(153 887)
(151 529)
(150 990)
(154 957)
(160 939)
(166 118)
(162 820)
(156 731)
(146 969)
(137 604)
(135 299)
(135 911)
(136 500)
(143 806)
(151 847)
(153 542)
(154 152)
(153 249)
(153 282)
(160 180)
(163 464)
(163 013)
(156 136)
(152 705)
(151 093)
(155 361)
(161 800)
Gross Profit
49 805
N/A
47 327
-5%
47 197
0%
47 184
0%
48 557
+3%
48 588
+0%
47 738
-2%
44 938
-6%
44 103
-2%
45 390
+3%
47 498
+5%
53 537
+13%
54 623
+2%
53 955
-1%
52 880
-2%
49 248
-7%
49 261
+0%
46 532
-6%
47 280
+2%
44 644
-6%
40 716
-9%
43 640
+7%
44 968
+3%
49 230
+9%
52 465
+7%
50 441
-4%
46 068
-9%
39 656
-14%
35 360
-11%
34 071
-4%
33 524
-2%
36 590
+9%
44 418
+21%
47 662
+7%
53 499
+12%
59 653
+12%
63 075
+6%
70 824
+12%
73 397
+4%
77 497
+6%
82 420
+6%
83 839
+2%
92 352
+10%
96 840
+5%
102 304
+6%
Operating Income
Operating Expenses
(24 332)
(22 935)
(24 446)
(23 473)
(22 926)
(24 287)
(26 122)
(27 023)
(28 509)
(29 614)
(29 988)
(30 971)
(30 036)
(29 780)
(29 875)
(30 162)
(31 995)
(32 578)
(33 014)
(33 067)
(34 522)
(37 091)
(38 713)
(41 816)
(43 804)
(43 304)
(44 029)
(43 408)
(41 985)
(42 004)
(42 006)
(42 273)
(43 025)
(46 083)
(49 642)
(53 175)
(57 531)
(61 712)
(64 508)
(67 188)
(71 967)
(76 320)
(83 694)
(90 865)
(98 786)
Selling, General & Administrative
(22 278)
(22 645)
(21 781)
(20 687)
(20 209)
(21 612)
(23 458)
(24 606)
(25 886)
(27 071)
(27 487)
(28 589)
(28 160)
(27 910)
(28 197)
(28 325)
(30 119)
(31 343)
(32 174)
(32 670)
(31 535)
(37 090)
(38 712)
(41 815)
(35 221)
(43 303)
(44 028)
(43 408)
(34 705)
(42 004)
(42 006)
(42 273)
(37 824)
(46 083)
(49 642)
(53 175)
(51 883)
(61 712)
(64 508)
(67 188)
(64 448)
(76 320)
(78 688)
(80 814)
(78 296)
Research & Development
(1 251)
(1 647)
(1 828)
(1 941)
(1 867)
(1 723)
(1 658)
(1 336)
(1 484)
(1 370)
(1 355)
(1 253)
(765)
(780)
(593)
(754)
(770)
0
0
0
(1 418)
0
0
0
(6 238)
0
0
0
(5 053)
0
0
0
(3 077)
0
0
0
(3 654)
0
0
0
(5 312)
0
(4 433)
(8 888)
(18 158)
Depreciation & Amortization
(802)
(836)
(834)
(843)
(850)
(901)
(996)
(1 069)
(1 138)
(1 170)
(1 144)
(1 127)
(1 110)
(1 090)
(1 085)
(1 083)
(1 106)
0
0
0
(1 568)
0
0
0
(2 344)
0
0
0
(2 226)
0
0
0
(2 124)
0
0
0
(1 994)
0
0
0
(2 206)
0
(573)
(1 162)
(2 331)
Other Operating Expenses
0
2 193
(3)
0
0
(51)
(10)
(12)
0
(3)
0
0
0
0
0
0
0
(1 235)
(840)
(397)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Operating Income
25 474
N/A
24 393
-4%
22 752
-7%
23 711
+4%
25 632
+8%
24 300
-5%
21 616
-11%
17 916
-17%
15 594
-13%
15 777
+1%
17 510
+11%
22 566
+29%
24 587
+9%
24 175
-2%
23 006
-5%
19 088
-17%
17 267
-10%
13 955
-19%
14 266
+2%
11 576
-19%
6 194
-46%
6 548
+6%
6 253
-5%
7 413
+19%
8 661
+17%
7 137
-18%
2 039
-71%
(3 753)
N/A
(6 625)
-77%
(7 933)
-20%
(8 482)
-7%
(5 683)
+33%
1 393
N/A
1 578
+13%
3 857
+144%
6 479
+68%
5 545
-14%
9 111
+64%
8 890
-2%
10 308
+16%
10 454
+1%
7 519
-28%
8 658
+15%
5 975
-31%
3 519
-41%
Pre-Tax Income
Interest Income Expense
(788)
(815)
(179)
457
(223)
(329)
(237)
(1 912)
(701)
(1 428)
(1 412)
(327)
(2 002)
(948)
(757)
(1 229)
9
(233)
(914)
(440)
547
1 546
1 607
3 414
4 397
4 833
3 419
(691)
(4 173)
(6 255)
(4 901)
(2 501)
(3 085)
(2 599)
(3 276)
(4 137)
(3 463)
(4 259)
(4 522)
(5 470)
(5 954)
(5 773)
(5 263)
(537)
154
Non-Reccuring Items
2 195
(179)
(221)
(219)
(226)
0
0
0
0
0
0
0
0
0
0
102
0
0
0
0
0
0
0
0
0
0
0
0
127
0
0
0
0
0
0
0
(43)
0
0
0
0
0
0
0
0
Gain/Loss on Disposition of Assets
(150)
(156)
(145)
(144)
7
0
0
16
18
18
18
(29)
(31)
0
0
0
0
0
0
0
(16)
0
0
0
(593)
0
0
0
59
0
0
0
122
0
0
0
(11)
0
0
0
(6)
0
0
0
(149)
Total Other Income
3 303
3 410
377
536
342
514
621
754
733
615
569
494
1 708
1 730
1 584
1 568
368
1 600
1 418
2 054
258
(1 133)
682
84
1 565
1 028
(492)
(401)
680
2 080
1 725
1 661
955
(312)
(1)
(207)
144
215
388
487
410
215
(2 708)
(2 702)
(3 074)
Pre-Tax Income
30 034
N/A
26 651
-11%
22 584
-15%
24 341
+8%
25 532
+5%
24 485
-4%
22 000
-10%
16 774
-24%
15 643
-7%
14 981
-4%
16 684
+11%
22 703
+36%
24 261
+7%
24 957
+3%
23 833
-5%
19 528
-18%
17 644
-10%
15 322
-13%
14 769
-4%
13 189
-11%
6 982
-47%
6 960
0%
8 542
+23%
10 910
+28%
14 031
+29%
12 997
-7%
4 965
-62%
(4 845)
N/A
(9 933)
-105%
(12 107)
-22%
(11 657)
+4%
(6 523)
+44%
(615)
+91%
(1 332)
-117%
580
N/A
2 135
+268%
2 172
+2%
5 067
+133%
4 755
-6%
5 325
+12%
4 903
-8%
1 960
-60%
687
-65%
2 737
+298%
449
-84%
Net Income
Tax Provision
(21 398)
(20 417)
(19 269)
(20 108)
577
1 032
1 496
2 837
(2 937)
(3 164)
(3 980)
(5 621)
(6 298)
(6 463)
(6 093)
(5 084)
(4 527)
(4 091)
(3 849)
(3 110)
(1 697)
(1 825)
(2 309)
(3 659)
(4 626)
(4 079)
(2 029)
773
2 438
3 254
3 170
2 623
1 225
1 043
1 062
226
802
297
(147)
(400)
(264)
334
(283)
(382)
(267)
Income from Continuing Operations
8 636
6 234
3 315
4 233
26 110
25 518
23 497
19 612
12 706
11 817
12 704
17 082
17 963
18 494
17 740
14 443
13 116
11 230
10 919
10 079
5 285
5 134
6 232
7 250
9 404
8 917
2 937
(4 072)
(7 495)
(8 854)
(8 487)
(3 899)
611
(289)
1 641
2 361
2 974
5 364
4 608
4 925
4 639
2 295
404
2 355
182
Net Income (Common)
8 636
N/A
6 233
-28%
7 489
+20%
8 407
+12%
26 110
+211%
25 518
-2%
23 497
-8%
19 612
-17%
12 706
-35%
11 817
-7%
12 704
+8%
17 082
+34%
17 963
+5%
18 494
+3%
17 740
-4%
14 443
-19%
13 116
-9%
11 230
-14%
10 919
-3%
10 079
-8%
5 285
-48%
5 134
-3%
6 232
+21%
7 250
+16%
9 404
+30%
8 917
-5%
2 937
-67%
(4 072)
N/A
(7 495)
-84%
(8 854)
-18%
(8 487)
+4%
(3 899)
+54%
611
N/A
(289)
N/A
1 641
N/A
2 361
+44%
2 974
+26%
5 364
+80%
4 608
-14%
4 925
+7%
4 639
-6%
2 295
-51%
404
-82%
2 355
+483%
182
-92%
EPS (Diluted)
392.54
N/A
283.31
-28%
340.4
+20%
350.29
+3%
1 135.21
+224%
1 063.25
-6%
979.04
-8%
817.16
-17%
529.41
-35%
492.37
-7%
529.33
+8%
711.75
+34%
748.45
+5%
770.58
+3%
739.16
-4%
601.79
-19%
546.5
-9%
467.91
-14%
454.95
-3%
419.95
-8%
220.2
-48%
213.91
-3%
259.66
+21%
302.08
+16%
391.83
+30%
375.91
-4%
123.03
-67%
-170.3
N/A
-313.52
-84%
-388.23
-24%
-358.59
+8%
-163.1
+55%
25.54
N/A
-12.08
N/A
68.66
N/A
98.74
+44%
124.42
+26%
224.37
+80%
192.75
-14%
206
+7%
194.06
-6%
95.99
-51%
16.9
-82%
98.49
+483%
7.63
-92%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett